Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-072580
Filing Date
2023-03-16
Accepted
2023-03-16 16:08:51
Documents
2
Group Members
CT SPV INVESTMENT LPIPG CAYMAN LPIPG USA SCO LP

Document Format Files

Seq Description Document Type Size
1 SC 13G d475220dsc13g.htm SC 13G 75342
2 EX-99.1 d475220dex991.htm EX-99.1 6797
  Complete submission text file 0001193125-23-072580.txt   83995
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87951 | Film No.: 23738839
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 RIGHTER PARKWAY, SUITE 260 WILMINGTON DE 19803
Business Address 1 RIGHTER PARKWAY, SUITE 260 WILMINGTON DE 19803 302-752-1055
Longview Innovation Corp. (Filed by) CIK: 0001963826 (see all company filings)

EIN.: 990384304 | State of Incorp.: DE
Type: SC 13G